Journal of Korean Dental Science

Korean Academy of Dental Science (대한치의학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Intermittent Parathyroid Hormone Administration on the Microstructure of Jaw Bone in the Ovariectomized Rats

  • Kang, Kang-su (Department of Oral and Maxillofacial Surgery, Graduate School of Clinical Dental Science, The Catholic University of Korea) ;
  • Kim, Kun-hyoung (Department of Oral and Maxillofacial Surgery, Graduate School of Clinical Dental Science, The Catholic University of Korea) ;
  • Heo, Hyun-a (Department of Oral and Maxillofacial Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Park, Suhyun (Department of Oral and Maxillofacial Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Pyo, Sung-woon (Department of Oral and Maxillofacial Surgery, Graduate School of Clinical Dental Science, The Catholic University of Korea)
  • Received : 2015.08.12
  • Accepted : 2015.12.13
  • Published : 2015.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Parathyroid hormone (PTH) therapy has drawn attention, as an alternative to anti-resorptive drugs since PTH accelerates bone density by anabolic action. The purpose of this study was to identify the effect of intermittent PTH administration on jaw bones of rat undergone bilateral ovariectomy. Materials and Methods: Nine female Sprague-Dawley rats were divided into three groups. PTH group was ovariectomized (OVX) to induce osteoporosis and PTH $30{\mu}g/kg$ was administered 1 week after the surgery. In OVX group, ovariectomy was performed and only vehicle was administered by subcutaneous injection 3 times per week. Control group was subjected to sham surgery. The animals were sacrificed 8 weeks after the surgery and specimens were obtained from ilium and upper and lower jaw bones. Histological investigation was carried out by using an optical microscope and micro-computed tomography was taken to examine structural property changes in each bone sample. Result: In the ilium, the bone volume ratio (bone volume/total volume, BV/TV) of PTH, OVX and control groups was $53.75%{\pm}7.57%$, $50.61%{\pm}12.89%$, $76.20%{\pm}5.92%$ (P=0.061) and bone mineral density (BMD) was $1.12{\pm}0.09$, $0.88{\pm}0.48$, $1.38{\pm}0.07g/cm^3$ (P=0.061). In the mandible, BV/TV of PTH, OVX and control groups was $64.60%{\pm}12.17%$, $58.26%{\pm}9.63%$, $67.54%{\pm}14.74%$(P=0.670) and BMD was $1.21{\pm}0.17$, $1.19{\pm}0.13$, $1.27{\pm}0.18g/cm^3$ (P=0.587). In the maxilla, BV/TV of PTH, OVX and control groups was $61.19%{\pm}8.92%$, $52.50%{\pm}11.22%$, $64.60%{\pm}12.17%$ (P=0.430) and BMD was $1.20{\pm}0.11$, $1.11{\pm}0.16$, $1.21{\pm}0.17g/cm^3$ (P=0.561). No statistically significant difference was found in any variables in all groups. Histological observation revealed that the ilium in OVX group demonstrated sparsely formed trabecular bones compared with other groups. However, upper and lower trabecular bones did not present significant differences. Conclusion: Intermittent administration of PTH appears to affect the microstructure of rat jaw bones, but statistical significance was not found. However, the measurements in this study partly implicated the possible anabolic effect of PTH in vivo.

Keywords

References

  1. Kasugai S. Dental implant treatment to osteoporosis patients. Clin Calcium. 2006; 16: 348-53.
  2. Ejiri S, Tanaka M, Watanabe N, Anwar RB, Yamashita E, Yamada K, Ikegame M. Estrogen deficiency and its effect on the jaw bones. J Bone Miner Metab. 2008; 26: 409-15. https://doi.org/10.1007/s00774-008-0870-4
  3. Teitelbaum AP, Pliam NB, Silve C, Abbott SR, Nissenson RA, Arnaud CD. Functional properties of parathyroid hormone receptors in kidney and bone. Adv Exp Med Biol. 1982; 151: 535-48. https://doi.org/10.1007/978-1-4684-4259-5_57
  4. Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA. Skeletal alterations in ovariectomized rats. Calcif Tissue Int. 1985; 37: 324-8. https://doi.org/10.1007/BF02554882
  5. Aggarwal P, Zavras A. Parathyroid hormone and its effects on dental tissues. Oral Dis. 2012; 18: 48-54. https://doi.org/10.1111/j.1601-0825.2011.01850.x
  6. Giro G, Coelho PG, Sales-Pessoa R, Pereira RM, Kawai T, Orrico SR. Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. J Oral Maxillofac Surg. 2011; 69: 1911-8. https://doi.org/10.1016/j.joms.2011.01.028
  7. Tanaka M, Ejiri S, Toyooka E, Kohno S, Ozawa H. Effects of ovariectomy on trabecular structures of rat alveolar bone. J Periodontal Res. 2002; 37: 161-5. https://doi.org/10.1034/j.1600-0765.2002.01601.x
  8. Bellido M, Lugo L, Castaneda S, Roman-Blas JA, Rufián-Henares JA, Navarro-Alarcon M, Largo R, Herrero-Beaumont G. PTH increases jaw mineral density in a rabbit model of osteoporosis. J Dent Res. 2010; 89: 360-5. https://doi.org/10.1177/0022034510363082
  9. Miller SC, Hunziker J, Mecham M, Wronski TJ. Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats. J Dent Res. 1997; 76: 1471-6. https://doi.org/10.1177/00220345970760080901
  10. Arita S, Ikeda S, Sakai A, Okimoto N, Akahoshi S, Nagashima M, Nishida A, Ito M, Nakamura T. Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats. J Bone Miner Metab. 2004; 22: 530-40. https://doi.org/10.1007/s00774-004-0520-4
  11. Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, García-Hernández PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010; 25: 404-14. https://doi.org/10.1359/jbmr.090731
  12. Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am. 2008; 90(Suppl 1): 120-7. https://doi.org/10.2106/JBJS.G.01443
  13. Mosekilde L, Sogaard CH, Danielsen CC, Torring O. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology. 1991; 129: 421-8. https://doi.org/10.1210/endo-129-1-421
  14. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344: 1434-41. https://doi.org/10.1056/NEJM200105103441904
  15. Barros SP, Silva MA, Somerman MJ, Nociti FH Jr. Parathyroid hormone protects against periodontitis-associated bone loss. J Dent Res. 2003; 82: 791-5. https://doi.org/10.1177/154405910308201006
  16. Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK. Teriparatide and osseous regeneration in the oral cavity. N Engl J Med. 2010; 363: 2396-405. https://doi.org/10.1056/NEJMoa1005361
  17. Ohkawa Y, Tokunaga K, Endo N. Intermittent administration of human parathyroid hormone (1- 34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora. J Orthop Sci. 2008; 13: 533-42. https://doi.org/10.1007/s00776-008-1275-x
  18. Rittmaster RS, Bolognese M, Ettinger MP, Hanley DA, Hodsman AB, Kendler DL, Rosen CJ. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab. 2000; 85: 2129-34.
  19. Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone. 2007; 40: 1434-46. https://doi.org/10.1016/j.bone.2007.03.017
  20. Tam CS, Heersche JN, Murray TM, Parsons JA. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology. 1982; 110: 506-12. https://doi.org/10.1210/endo-110-2-506
  21. Gunness M, Hock JM. Anabolic effect of parathyroid hormone on cancellous and cortical bone histology. Bone. 1993; 14: 277-81. https://doi.org/10.1016/8756-3282(93)90152-Z
  22. Langub MC, Monier-Faugere MC, Qi Q, Geng Z, Koszewski NJ, Malluche HH. Parathyroid hormone/parathyroid hormone-related peptide type 1 receptor in human bone. J Bone Miner Res. 2001; 16: 448-56. https://doi.org/10.1359/jbmr.2001.16.3.448
  23. Corsini MS, Faraco FN, Castro AA, Onuma T, Sendyk WR, Shibli JA. Effect of systemic intermittent administration of human parathyroid hormone (rhPTH[1-34]) on the resistance to reverse torque in rabbit tibiae. J Oral Implantol. 2008; 34: 298-302. https://doi.org/10.1563/1548-1336-34.6.298
  24. Hori M, Uzawa T, Morita K, Noda T, Takahashi H, Inoue J. Effect of human parathyroid hormone (PTH(1-34)) on experimental osteopenia of rats induced by ovariectomy. Bone Miner. 1988; 3: 193-9.
  25. Duarte PM, César-Neto JB, Sallum AW, Sallum EA, Nociti FH Jr. Effect of estrogen and calcitonin therapies on bone density in a lateral area adjacent to implants placed in the tibiae of ovariectomized rats. J Periodontol. 2003; 74: 1618-24. https://doi.org/10.1902/jop.2003.74.11.1618
  26. Kuroshima S, Kovacic BL, Kozloff KM, McCauley LK, Yamashita J. Intra-oral PTH administration promotes tooth extraction socket healing. J Dent Res. 2013; 92: 553-9. https://doi.org/10.1177/0022034513487558
  27. Marco F, Milena F, Gianluca G, Vittoria O. Periimplant osteogenesis in health and osteoporosis. Micron. 2005; 36: 630-44. https://doi.org/10.1016/j.micron.2005.07.008
  28. Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev. 2005; 26: 688-703. https://doi.org/10.1210/er.2004-0006
  29. Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M. Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose. Toxicol Pathol. 2004; 32: 426-38. https://doi.org/10.1080/01926230490462138
  30. Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Linda Y, Nold JB. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol. 2002; 30: 312-21. https://doi.org/10.1080/01926230252929882